SEC-sourced researchBeta

ADTX

Aditxt, Inc.

US markets

Data passport

CIK: 0001726711
Exchange: OTC
Business activity: Pharmaceutical Preparations · SIC 2834
Financial inputs: 6/6
Filing date: Oct 7, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 8:04 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

ADTX · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2024	133,985.0000	Mar 31, 2026
December 2025	3,195.0000	Mar 31, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	3,195.0000	-43,101,451.0000	-25,688,359.0000	16,516,781.0000	12,563,099.0000	Mar 31, 2026
December 2024	133,985.0000	-40,353,497.0000	-16,762,121.0000	32,144,390.0000	23,857,994.0000	Mar 31, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

25/100

Profitability0

Growth0

Balance sheet24

Cash generation0

Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$3.2K	Jan 1, 2025 – Dec 31, 2025	Mar 31, 2026	10-K
Previous period revenueRevenues	$133.99K	Jan 1, 2024 – Dec 31, 2024	Mar 31, 2026	10-K
Net incomeNetIncomeLoss	-$43.1M	Jan 1, 2025 – Dec 31, 2025	Mar 31, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$25.69M	Jan 1, 2025 – Dec 31, 2025	Mar 31, 2026	10-K
Total assetsAssets	$16.52M	Dec 31, 2025	Mar 31, 2026	10-K
Total liabilitiesLiabilities	$12.56M	Dec 31, 2025	Mar 31, 2026	10-K

New filings

Explore methodology ↗